Inspired by the ability of SERS nanoantennas to provide an integrated platform to enhance disease targeting in vivo, we developed a highly sensitive probe for in vivo tumoral recognition with the capacity to target specific cancer biomarkers such as epidermal growth factor receptors (EGFR) on human cancer cells and xenograft tumour models. Here, we used ~90 nm gold nanoparticles capped by a Raman reporter, encapsulated and entrapped by larger polymers and a FDA antibody-drug conjugate -A C C E P T E D M A N U S C R I P T ACCEPTED MANUSCRIPT 2 Cetuximab (Erbitux®) -that specifically targets EGFR and turns off a main signalling cascade for cancer cells to proliferate and survive. These drug/SERS gold nanoantennas present a high Raman signal both in cancer cells and in mice bearing xenograft tumours. Moreover, the Raman detection signal is accomplished simultaneously by extensive tumour growth inhibition in mice, making these gold nanoantennas ideal for cancer nanotheranostics, i.e. tumour detection and tumoral cell inhibition at the same time. A C C E P T E D M A N U S C R I P T ACCEPTED MANUSCRIPT 25 GRAPHICAL ABSTRACT Antibody-Drug gold nanoantennas to use as nanotheranostic tool for in vivo imaging/detection and tumour inhibition. These smart Drug-Raman NPs can easily bind to EGF receptors, blocking the EGF protein from reaching the cancer cells and inhibit the signalling cascade, consequently stop proliferation and survival of targeted cells.
INTRODUCTION
Surface-enhanced Raman Spectroscopy (SERS) has led the way in terms of use of spectroscopic methods for signal enhancement by nanostructured metal surfaces towards in vivo tracking of biomolecules trafficking. [1] [2] [3] When light interacts with a molecule, it can be absorbed, transmitted, or scattered, which may be a consequence from an elastic (Rayleigh scattering) or inelastic (Raman scattering) collision. Raman spectroscopy relies on the modification of frequency of light when it is inelastically scattered by molecules or atoms resulting in fingerprint information on molecular structure or environment. [4] SERS has been extensively used for molecular/ion detection and bioimaging applications since it minimizes photoblinking or photobleaching from conventional fluorophores, decreases signal-to-noise ratio in vitro and in vivo, as usually Raman reporters are stable and with large quantum yields. [5] [6] [7] [8] Colloidal metal nanoparticles (especially silver and gold) act as good SERS enhancers, via surface electromagnetic field enhancement and chemical contribution. [9] Gold nanoparticles (AuNPs) covered by Raman reporters have been used for SERS to detect cancer cells in vitro and tumours in vivo. [10] [11] [12] [13] Raman reporters combined with AuNPs produce an optical contrast to distinguish between cancer and normal cells and their conjugation with antibodies allowed them to determine the expression of relevant biomarkers in molecular imaging. [13] Qian et al. reported that, when conjugated to tumour targeting ligands, these SERS-NPs were able to target tumour markers A C C E P T E D M A N U S C R I P T ACCEPTED MANUSCRIPT 3 at surface of malignant cells, such as epidermal growth factor receptor (EGFR) and used to locate tumours in cancer models. [14] Nevertheless, using SERS-NPs as a nanotheranostic tool to detect xenograft tumours and the same time inhibit tumour size and progression has never been reported before.
Here, we used ~90 nm AuNPs covered by DTTC (3,3'-Diethylthiatricarbocyaniniodid)
Raman reporters, that were encapsulated and entrapped by larger polymers (i.e. 5000 Da thiol-and COOH-modified polyethylene glycol coat). These polymers served as substrates for the binding of a FDA approved antibody-drug conjugate, the Cetuximab (Erbitux®, Merck).
Cetuximab is a monoclonal antibody that specifically targets EGFR, a receptor that often appears in high amounts on the surface of cancer cells and gives a signal that causes those cells to divide uncontrollably. Cetuximab binds to such receptors and turns off that signal [15] (see Figure 1 ). 
Figure 1. (A) Antibody

RESULTS AND DISCUSSION
Spherical naked AuNPs with an average diameter of 91.4±8.9 nm confirmed by transmission electron microscopy (TEM) (Figure 2A,B We next investigated the capacity of SERS-coded antibody/drug AuNP conjugates to provide spectroscopic signatures in in vitro HT-adenocarcinoma cells from colorectal cancer that overexpress EGFR. [24] Cells were incubated for 24 hours with Drug-Raman NPs (1.78×10 9
NPs) and confocal microscopy images were captured in order to measure lysosome signal, using LysoTracker Green ( Figure 3A) and DTTC emission signal ( Figure 3B) . The EGFR receptor is one of the key membrane proteins located on the cell surface and for this reason it is expected that the Drug-Raman NPs would be mostly disseminated in the cell membrane.
This is clearly seen in Figure 3B where the DTTC signal is located mainly in cell membrane and cell membrane associated contents. Some co-localization was detected as Drug-Raman In order to test tumour size and nanoparticle uptake and biodistribution in whole body mice and predominantly in xenograft tumour tissue, a xenograft tumour mice model was developed.
Briefly, B6 albino female mice were injected in the right leg with HT-29-luc-D6 Bioware® (Figure 4D) . Severe cancer cells infiltration is also noted in Raman NPs treated group (Figure 4E) . In the Drug-Raman NPs treated group there was a significant decrease in the incidence and severity of tumour clones in the whole tumour tissue, revealing the capacity of Drug-Raman NPs in reducing tumour cells in a xenograft tumour in mice (Figure 4F) .
Almost no cancer clones can be observed at the recovered tumour area treated with Drug-Raman NPs. A large area of dead cancer cells without nuclei can be clearly seen in drug-Raman NP-treated tumours (Figure 4F) . Additional tumour tissue slides for sham, Raman NP and drug-Raman NP groups can be found in Fig Seventy-two hours after the tail-vein injection, the SERS spectra of the tumour site were measured through the tumour tissues excised from the mice. The signal of the tumour site perfectly resembled the SERS spectra of the pure Drug-Raman NPs (see Figure 2D) , whereas a very weak SERS signal was detected from Raman NPs only (without antibody-drug
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11 conjugate) or other anatomical locations (i.e., the opposite leg) (Figure 5D) . The SERS measurements were carried out at the three locations to confirm the accumulation, which was in accord with the epi-fluorescence imaging (Figure 5B) . The in vivo SERS spectra were identical to that obtained in vitro, however the absolute intensities of the characteristic SERS peak at 508 cm -1 for Drug-Raman NPs were higher (~4.5-fold), when compared to Raman-NPs only. These findings assured us of the value of our gold nanoantennas as SERS reporters for in vivo applications. 
MATERIALS AND METHODS
Synthesis of drug/Raman coded AuNPs
Spherical AuNPs with ~90 nm were prepared using a seeded growth approach as described elsewhere. [29] Then, AuNPs were incubated with freshly prepared DTTC reporter (3,3 
Cytotoxicity evaluation
Standard MTT [3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazoliumbromide] reduction assay (Invitrogen) was performed to determine cytotoxicity following transfection with Raman-NPs and drug/Raman-NPs as described before. [30] . After 24 hours, NPs (1.78×10 9
NPs) were added to the wells and cells further incubated for 24, 48 and 72 hours. Following medium removal, cells were washed twice with sterile 1× PBS and incubated for 2 hours with 300 µl of fresh medium with serum supplemented with 16.7 µl of sterile MTT stock solution (5 mg/mL in 1× PBS). Next, medium was removed, formazan crystals resuspended in 300 µl of dimethyl sulfoxide (Sigma), and absorbance measured at 540 nm as a working wavelength and 630 nm as reference using a Microplate reader Infinite M200 with Absorbance module (Tecan). Cell viability was normalized to that of cells cultured in the culture medium with PBS treatment.
In vivo targeting of drug/Raman coded AuNPs
Prior to nanoparticle's injection, B6 albino mice were injected in the right leg with ( 
